Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Till Milde

Showing results (111-120 of 161) with videos related to

Pageof 17
Sort By:
Neuro-Oncology|August 17, 2022
BH3 mimetics targeting BCL-XL impact the senescent compartment of pilocytic astrocytomaFlorian Selt, Romain Sigaud, Gintvile Valinciute, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 12, 2018
The Senescence-associated Secretory Phenotype Mediates Oncogene-induced Senescence in Pediatric Pilocytic AstrocytomaJuliane L Buhl, Florian Selt, Thomas Hielscher, et al.
Nature Communications|September 21, 2021
Radiation-induced gliomas represent H3-/IDH-wild type pediatric gliomas with recurrent PDGFRA amplification and loss of CDKN2A/BMaximilian Y Deng, Dominik Sturm, Elke Pfaff, et al.
Acta Neuropathologica|June 9, 2018
Primary intracranial spindle cell sarcoma with rhabdomyosarcoma-like features share a highly distinct methylation profile and DICER1 mutationsChristian Koelsche, Martin Mynarek, Daniel Schrimpf, et al.
Acta Neuropathologica|May 17, 2018
Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic featuresMaximilian Y Deng, Martin Sill, Jason Chiang, et al.
Neuro-Oncology|May 14, 2024
Resistance, rebound, and recurrence regrowth patterns in pediatric low-grade glioma treated by MAPK inhibition: A modified Delphi approach to build international consensus-based definitions-International Pediatric Low-Grade Glioma CoalitionPatricia O'Hare, Tabitha Cooney, Peter de Blank, et al.
Nature Communications|July 27, 2023
MAPK inhibitor sensitivity scores predict sensitivity driven by the immune infiltration in pediatric low-grade gliomasRomain Sigaud, Thomas K Albert, Caroline Hess, et al.
Journal for Immunotherapy of Cancer|January 13, 2023
Tacedinaline (CI-994), a class I HDAC inhibitor, targets intrinsic tumor growth and leptomeningeal dissemination in MYC-driven medulloblastoma while making them susceptible to anti-CD47-induced macrophage phagocytosis via NF-kB-TGM2 driven tumor inflammationViktoria Marquardt, Johanna Theruvath, David Pauck, et al.
Cancers|May 14, 2022
Infants and Newborns with Atypical Teratoid Rhabdoid Tumors (ATRT) and Extracranial Malignant Rhabdoid Tumors (eMRT) in the EU-RHAB Registry: A Unique and Challenging PopulationKarolina Nemes, Pascal D Johann, Mona Steinbügl, et al.
Acta Neuropathologica|October 11, 2025
Molecular characterization and clinical features of diffuse midline glioma in the pediatric precision oncology registry INFORMElke Pfaff, Kathrin Schramm, Mirjam Blattner-Johnson, et al.
Pageof 17

Showing results (111-120 of 161) with videos related to

Sort By:
Pageof 17
Neuro-Oncology|August 17, 2022
BH3 mimetics targeting BCL-XL impact the senescent compartment of pilocytic astrocytomaFlorian Selt, Romain Sigaud, Gintvile Valinciute, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 12, 2018
The Senescence-associated Secretory Phenotype Mediates Oncogene-induced Senescence in Pediatric Pilocytic AstrocytomaJuliane L Buhl, Florian Selt, Thomas Hielscher, et al.
Nature Communications|September 21, 2021
Radiation-induced gliomas represent H3-/IDH-wild type pediatric gliomas with recurrent PDGFRA amplification and loss of CDKN2A/BMaximilian Y Deng, Dominik Sturm, Elke Pfaff, et al.
Acta Neuropathologica|June 9, 2018
Primary intracranial spindle cell sarcoma with rhabdomyosarcoma-like features share a highly distinct methylation profile and DICER1 mutationsChristian Koelsche, Martin Mynarek, Daniel Schrimpf, et al.
Acta Neuropathologica|May 17, 2018
Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic featuresMaximilian Y Deng, Martin Sill, Jason Chiang, et al.
Neuro-Oncology|May 14, 2024
Resistance, rebound, and recurrence regrowth patterns in pediatric low-grade glioma treated by MAPK inhibition: A modified Delphi approach to build international consensus-based definitions-International Pediatric Low-Grade Glioma CoalitionPatricia O'Hare, Tabitha Cooney, Peter de Blank, et al.
Nature Communications|July 27, 2023
MAPK inhibitor sensitivity scores predict sensitivity driven by the immune infiltration in pediatric low-grade gliomasRomain Sigaud, Thomas K Albert, Caroline Hess, et al.
Journal for Immunotherapy of Cancer|January 13, 2023
Tacedinaline (CI-994), a class I HDAC inhibitor, targets intrinsic tumor growth and leptomeningeal dissemination in MYC-driven medulloblastoma while making them susceptible to anti-CD47-induced macrophage phagocytosis via NF-kB-TGM2 driven tumor inflammationViktoria Marquardt, Johanna Theruvath, David Pauck, et al.
Cancers|May 14, 2022
Infants and Newborns with Atypical Teratoid Rhabdoid Tumors (ATRT) and Extracranial Malignant Rhabdoid Tumors (eMRT) in the EU-RHAB Registry: A Unique and Challenging PopulationKarolina Nemes, Pascal D Johann, Mona Steinbügl, et al.
Acta Neuropathologica|October 11, 2025
Molecular characterization and clinical features of diffuse midline glioma in the pediatric precision oncology registry INFORMElke Pfaff, Kathrin Schramm, Mirjam Blattner-Johnson, et al.
Pageof 17